Nano-X Investors Face August 11 Deadline in Securities Class Action

The litigation centers on allegations that Nano-X and certain executives issued misleading statements regarding the company's operational efficiency and manufacturing capacity. Plaintiffs claim the company failed to disclose that its South Korean chip production facility was misaligned with market demand, leading to unsustainable cash burn and escalating operating expenses. These issues culminated in a $17.5 million long-lived asset impairment charge and a broader manufacturing restructuring plan.

On April 20, 2026, the company disclosed a $33.4 million quarterly net loss and the departure of its CFO, triggering a 24.39% drop in share price—a decline of $0.695 per share. The lawsuit asserts that investors purchased shares at artificially inflated prices during the class period while the company simultaneously raised $15 million through a registered direct offering in November 2025. Institutional holders, including pension funds and asset managers, are encouraged to assess their potential recovery options as part of their fiduciary duties. Legal counsel from Levi & Korsinsky, LLP noted that participating as a lead plaintiff offers investors oversight of litigation strategy and settlement negotiations without additional out-of-pocket costs.